A new Alzheimer's drug, lecanumab, is likely to prompt soul searching about whether you would recommend this, or not recommend this, a researcher says.
An Alzheimer's Therapy Scores Winning Results
Comment
Show comments
Hide Comments
A new Alzheimer's drug, lecanumab, is likely to prompt soul searching about whether you would recommend this, or not recommend this, a researcher says.
